Pharmaceutical Industry Blog

Last Updated: August 23, 2026 TL;DR: Papua New Guinea regulates medicines through the Pharmaceutical Services Standards Branch (PSSB) of the National Department of Health, which administers the Medicines and Cosmetics Act 1999 and reviews products through a marketing authorization system launched with WHO support in August 2019; a Draft Medicines Bill was under review as of August 2025, following a 2024 WHO Global Benchmarking assessment that made Papua New Guinea the first P

Last Updated: August 23, 2026 TL;DR: Tajikistan regulates medicines through the Ministry of Health and Social Protection of the Population (MOHSPP), which handles state registration, while the State Supervision Service for Health Care and Social Protection of the Population — under MOHSPP — conducts expert evaluation of registration dossiers under Law No. 39 "On Pharmaceuticals and Pharmaceutical Activities," in force since 6 August 2001. Tajikistan is a CIS member but not pa

Last Updated: August 23, 2026 TL;DR: Honduras regulates medicines through the Agencia de Regulación Sanitaria (ARSA), created by Executive Decree PCM-032-2017 in April 2017 as a deconcentrated arm of the Secretaría de Salud and later elevated to full legal standing under Decree 7-2021, which registers pharmaceutical products for human use under the Reglamento Técnico Centroamericano (RTCA) 11.03.59 — the Central American region's harmonized sanitary-registration framework — r

Last Updated: August 23, 2026 TL;DR: Cuba's medicines are regulated by CECMED (Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos), founded April 21, 1989 under the Ministry of Public Health (MINSAP); CECMED issues the Registro Sanitario required before any medicine can be sold domestically, has held WHO Collaborating Centre status for Health Technology since 2014, and is one of only eight PAHO/WHO-designated National Regulatory Authorities of Regi

Last Updated: August 23, 2026 TL;DR: The Dominican Republic regulates medicines through DIGEMAPS (Dirección General de Medicamentos, Alimentos y Productos Sanitarios), part of the Ministerio de Salud Pública, under the framework of Decree 246-06; every product requires a Sanitary Register valid for five years, and since 2015 a simplified registration pathway for qualifying products has cut typical processing time to roughly four months. Unlike several markets in this series,

Last Updated: August 23, 2026 TL;DR: Jordan regulates medicines through the Jordan Food and Drug Administration (JFDA), established in 2003 under the Ministry of Health, which registers pharmaceutical products in CTD format, licenses importers, manufacturers and wholesalers, and has applied for PIC/S membership (application filed January 2021, rapporteurs appointed 2022). Public-sector pharmaceutical purchasing runs primarily through the Joint Procurement Department (JPD, for